Bacil Pharma Limited has secured approval from the Registrar of Companies for the name "Bacil Research & Development Private Limited" for its proposed wholly-owned subsidiary. This approval is a significant step forward in establishing the new entity, with the incorporation process currently in progress. The company intends to provide further updates upon the completion of the incorporation and receipt of the official Certificate. This development signals Bacil Pharma's progress towards expanding its operational capabilities with a dedicated R&D subsidiary.